FDA Warns Medtronic Over Heart Rhythm Unit
Medtronic Inc. announced Wednesday that it had received a warning letter from the U.S. Food and Drug Administration regarding an inspection of its heart rhythm device facility over problems the agency...To view the full article, register now.
Already a subscriber? Click here to view full article